SEC Form 4/A · accession 0001235802-15-000066
UROPLASTY INC · UPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert Kill
Officer — President and CEO · Director
Period of report
Mar 31, 2015
Accepted (ET)
May 13, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890846
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 31, 2015 | D | 385,000 | — | D | 0 | I | By Trust |
| Common StockF1,F3 | Mar 31, 2015 | D | 140,000 | — | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 was amended to correct the amount of the shares directly and indirectly held.
- F2Disposed of pursuant to merger agreement between issuer and Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix"), in exchange for 279,748 shares of Cogentix common stock on the effective date of the merger.
- F3These shares are subject to restricted stock assumed by Cogentix in the merger and replaced with 101,726 shares of Cogentix stock.